Thu, October 13, 2022

Andrew Berens Upgraded (BGNE) to Buy and Increased Target to $200 on, Oct 13th, 2022

Andrew Berens of SVB Leerink, Upgraded "BeiGene, Ltd." (BGNE) to Buy and Increased Target from $177 to $200 on, Oct 13th, 2022.

Andrew has made no other calls on BGNE in the last 4 months.



There is 1 other peer that has a rating on BGNE. Out of the 1 peers that are also analyzing BGNE, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Xiling Chen of "JP Morgan" Initiated at Buy and Held Target at $296 on, Tuesday, August 9th, 2022